Concepedia

Jon C. Jones

JC

21

Publications

2.6K

Citations

19

H-Index

1998

Active since

Affiliations

Amgen (United States)(Current)

Fred Hutch Cancer Center

University of Washington

Eureka Therapeutics (United States)

Memorial Sloan Kettering Cancer Center

Jon C. Jones is an author at Amgen (United States) specializing in medicine, tumor biology, and tumor microenvironment.

ORCID

Top concepts

Publications per year

1998–2020

21

Publications

21

RANK ligand mediates progestin-induced mammary epithelial proliferation and carcinogenesis

Eva González‐Suárez, Allison P. Jacob, Jon C. Jones et al. · Nature · 2010 · 583 citations

, , +6

A Novel Model of Inflammatory Bowel Disease: Mice Deficient for the Multiple Drug Resistance Gene, <i>mdr1a</i>, Spontaneously Develop Colitis

C Panwala, Jon C. Jones, Joanne L. Viney · The Journal of Immunology · 1998 · 567 citations · Full text

GPRC5D is a target for the immunotherapy of multiple myeloma with rationally designed CAR T cells

Eric L. Smith, Kim Harrington, Reed Masakayan et al. · Science Translational Medicine · 2019 · 373 citations · Full text

RANKL acts directly on RANK‐expressing prostate tumor cells and mediates migration and expression of tumor metastasis genes

Allison Armstrong, Robert E. Miller, Jon C. Jones et al. · The Prostate · 2007 · 177 citations · Full text

Imaging CAR T cell therapy with PSMA-targeted positron emission tomography

Il Minn, David Huss, Hye-Hyun Ahn et al. · Science Advances · 2019 · 132 citations · Full text

Rows per page

1–5 of 21